Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor
OriginalsprogEngelsk
TidsskriftBreast Cancer Research and Treatment
Udgave nummer91
Sider (fra-til)217-225
ISSN0167-6806
StatusUdgivet - 2005

ID: 93399